Skip to main content
STAA
NASDAQ Industrial Applications And Services

STAAR Surgical Reports Record Q1 Sales and Return to Profitability, Exceeding Expectations

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$34.679
Mkt Cap
$1.456B
52W Low
$15.585
52W High
$30.81
52W Position info
123% above low
Off High info
at 52W high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

STAA has more than doubled off its 52-week low of $15.585.

Summary

STAAR Surgical announced a strong Q1 2026, achieving record net sales of $93.5 million and returning to profitability with a net income of $5.2 million, a significant turnaround from the prior year's losses.


Key Events · Earnings and Guidance · STAA

  • Record Q1 Net Sales

    Net sales for Q1 2026 reached $93.5 million, a 119.6% increase compared to $42.6 million in Q1 2025, primarily driven by strong performance in China.

  • Return to Profitability

    The company reported a net income of $5.2 million ($0.10 diluted EPS) for Q1 2026, a significant improvement from a net loss of $54.2 million ($-1.10 diluted EPS) in Q1 2025.

  • Significant Gross Margin Improvement

    Gross profit margin increased to 73.6% in Q1 2026 from 65.8% in Q1 2025, reflecting cost reduction initiatives and improved production volumes.

  • Reduced Restructuring Charges

    Restructuring, impairment, and related charges decreased substantially to $2.7 million in Q1 2026 from $22.7 million in Q1 2025.


Analysis · STAA · Industrial Applications And Services

STAAR Surgical has reported a significant financial turnaround in Q1 2026, moving from a substantial net loss in the prior year to profitability. Net sales more than doubled year-over-year, driven by strong performance in China, and gross margins improved considerably. This marks a strong recovery from fiscal year 2025, which saw a significant drop in sales and a widened net loss. While cash and investments decreased in Q1 due to front-loaded payments, the company anticipates generating cash for the remainder of the year. This full quarterly report confirms and elaborates on the positive preliminary results announced earlier, reinforcing a positive shift in the company's operational and financial health.

How filings like this one have moved

In the 30 days to Oct 3, 2026, 40.9% of the 320 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, STAA was trading at $34.68 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $15.59 to $30.81. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

STAA - Latest Insights

STAA
Sep 25, 2026, 11:49 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $20.28
Real-time Price: $22.47 info
Change: +$2.19 (+11%) info
Market Cap: $1.127B info
STAA
Aug 12, 2026, 4:11 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $22.92
Real-time Price: $22.47 info
Change: -$0.450 (-2%) info
Market Cap: $1.127B info
STAA
Aug 12, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $24.40
Real-time Price: $22.47 info
Change: -$1.93 (-8%) info
Market Cap: $1.127B info
STAA
Aug 06, 2026, 11:04 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.89
Real-time Price: $22.47 info
Change: -$0.420 (-2%) info
Market Cap: $1.127B info
STAA
Jul 16, 2026, 6:04 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $25.59
Real-time Price: $22.47 info
Change: -$3.12 (-12%) info
Market Cap: $1.127B info